Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.71 [0.49-1.01],0.0580006177869175
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.07 [0.65-1.75],0.803295168486198
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.72 [0.27-1.94],0.520797597968724
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.22 [0.97-1.53],0.0930276784160293
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,4,0.98 [0.71-1.35],0.902342927501619
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.93 [0.85-1.02],0.125519250521733
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.01 [0.91-1.12],0.853785684767617
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,REN,Renin,Inverse variance weighted,12,1.04 [0.91-1.20],0.557416768961211
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SCG2,Secretogranin-2,Inverse variance weighted,3,0.73 [0.35-1.50],0.388875492209652
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.27 [1.05-1.53],0.0145137086138003
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.02 [0.95-1.11],0.523682458591024
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.00 [0.83-1.21],0.990702707907419
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,AGRP,Agouti-related protein,Inverse variance weighted,20,1.03 [0.91-1.17],0.623490653145641
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.13 [1.00-1.26],0.0442575128604567
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NRP2,Neuropilin-2,Inverse variance weighted,26,0.92 [0.83-1.03],0.142633771826169
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.93 [0.69-1.27],0.660799775409575
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CST6,Cystatin-M,Inverse variance weighted,32,1.14 [1.02-1.28],0.0241322068614598
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,0.98 [0.54-1.79],0.945365701556174
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RTBDN,Retbindin,Inverse variance weighted,5,0.88 [0.70-1.10],0.255834994363687
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,1.02 [0.80-1.29],0.887330861388924
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,1.12 [0.84-1.51],0.440156414045077
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MMP13,Collagenase 3,Inverse variance weighted,2,0.63 [0.32-1.22],0.167170582794427
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PSAP,Prosaposin,Inverse variance weighted,13,1.13 [1.00-1.28],0.0598146748928852
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,1.01 [0.92-1.10],0.866926822176356
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GRN,Progranulin,Inverse variance weighted,46,1.02 [0.95-1.09],0.637706896398482
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.99 [0.89-1.10],0.81615949191169
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.00 [0.86-1.16],0.996037554299601
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,0.84 [0.73-0.97],0.0175420156420496
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.02 [0.85-1.23],0.824722358365604
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,24,0.96 [0.88-1.05],0.366463069953639
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.01 [0.94-1.09],0.73585850751648
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,45,1.05 [0.98-1.11],0.146930857465836
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LCN15,Lipocalin-15,Inverse variance weighted,22,1.07 [1.00-1.13],0.0484159703992528
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CHGB,Secretogranin-1,Inverse variance weighted,33,0.99 [0.93-1.05],0.711325147934572
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.88 [0.75-1.02],0.0858757080344424
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CST3,Cystatin-C,Inverse variance weighted,13,1.06 [0.94-1.19],0.347427465104771
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,24,1.02 [0.90-1.15],0.780135041889323
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,THBD,Thrombomodulin,Inverse variance weighted,16,1.04 [0.93-1.16],0.456778778701232
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,1.09 [0.92-1.30],0.316449820729749
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.07 [0.98-1.17],0.110255797722499
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CHGA,Chromogranin-A,Inverse variance weighted,8,0.94 [0.80-1.10],0.418195422339899
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.99 [0.84-1.16],0.870529312097003
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,1.01 [0.94-1.08],0.888665434178613
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CFC1,Cryptic protein,Inverse variance weighted,11,1.12 [0.78-1.61],0.552433982833569
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NRP1,Neuropilin-1,Inverse variance weighted,26,1.02 [0.93-1.12],0.698787591357749
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NEO1,Neogenin,Wald ratio,1,0.77 [0.46-1.27],0.301786240453365
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KLK8,Kallikrein-8,Inverse variance weighted,17,1.02 [0.92-1.13],0.749795942212167
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,24,0.98 [0.89-1.07],0.650637741835394
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,UMOD,Uromodulin,Inverse variance weighted,62,1.03 [0.98-1.08],0.192750773414243
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,0.97 [0.85-1.11],0.657491777980107
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.95 [0.81-1.12],0.547410473841433
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,UNC5D,Netrin receptor UNC5D,Inverse variance weighted,2,1.87 [0.69-5.06],0.219694793644177
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CFD,Complement factor D,Inverse variance weighted,12,0.95 [0.85-1.08],0.447460690250941
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.24 [0.84-1.81],0.274764725022401
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.87 [0.59-1.28],0.4768358751273
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SEMA3F,Semaphorin-3F,Inverse variance weighted,46,1.02 [0.92-1.14],0.681945208789974
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.00 [0.94-1.06],0.949893668025603
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.00 [0.84-1.21],0.960317372884846
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,6,1.15 [0.89-1.50],0.292665136813913
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,0.94 [0.78-1.13],0.505593464838481
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL15,Interleukin-15,Inverse variance weighted,35,0.95 [0.85-1.06],0.333939883820476
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,BGLAP,Osteocalcin,Inverse variance weighted,10,0.88 [0.69-1.13],0.313394376287592
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MMP3,Stromelysin-1,Inverse variance weighted,35,1.04 [0.96-1.14],0.352615505675384
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.16 [0.82-1.62],0.39831975365869
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD83,CD83 antigen,Inverse variance weighted,19,1.00 [0.87-1.14],0.95933587544055
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,10,1.18 [0.95-1.46],0.13605006680448
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,31,0.98 [0.90-1.07],0.723631142584734
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.99 [0.76-1.29],0.962419595120946
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.03 [0.74-1.44],0.861115713495848
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.99 [0.78-1.25],0.904568012361281
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.94 [0.88-1.01],0.0761736371839237
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,0.99 [0.85-1.16],0.907936257147032
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.01 [0.82-1.25],0.901734851283487
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,0.99 [0.91-1.07],0.725687055298226
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,24,0.97 [0.88-1.08],0.607534215105909
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,0.94 [0.86-1.03],0.192870031307102
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,1.00 [0.95-1.05],0.978310398319391
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KLK4,Kallikrein-4,Inverse variance weighted,20,1.03 [0.95-1.12],0.496260803069179
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.94 [0.74-1.20],0.635171613151422
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.91-1.07],0.73738463376162
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PGF,Placenta growth factor,Inverse variance weighted,8,0.72 [0.55-0.95],0.0216274527140793
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ALCAM,CD166 antigen,Inverse variance weighted,11,0.96 [0.82-1.13],0.643882184604189
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.11 [1.03-1.19],0.0056281640390284
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,0.96 [0.80-1.16],0.683507047554419
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CTRB1,Chymotrypsinogen B,Inverse variance weighted,43,0.91 [0.86-0.97],0.0050938373458675
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SDC1,Syndecan-1,Inverse variance weighted,14,1.05 [0.90-1.23],0.540324609733509
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.97 [0.90-1.05],0.405775254220901
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,1.05 [0.88-1.25],0.595178699974865
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,0.93 [0.84-1.02],0.124138906694409
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PRSS2,Trypsin-2,Inverse variance weighted,22,1.00 [0.87-1.14],0.947458051615199
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,23,1.13 [1.01-1.26],0.0349345122300881
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,0.93 [0.84-1.04],0.226771263367866
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PTH,Parathyroid hormone,Inverse variance weighted,11,1.12 [0.92-1.36],0.263805660074926
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PALM,Paralemmin-1,Inverse variance weighted,10,0.92 [0.77-1.12],0.412700254879844
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,1.13 [1.00-1.27],0.0590592732331545
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.86 [0.65-1.15],0.318622837092221
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,1.27 [0.84-1.90],0.251927407378994
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.99 [0.93-1.06],0.796668663907724
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,26,1.08 [0.96-1.22],0.190639541681285
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PRSS8,Prostasin,Inverse variance weighted,19,0.98 [0.83-1.15],0.761289929005022
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KITLG,Kit ligand,Inverse variance weighted,31,1.19 [1.03-1.37],0.0173094173977116
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.08 [0.58-2.02],0.806053980592761
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RETN,Resistin,Inverse variance weighted,28,0.96 [0.89-1.03],0.228173562271541
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,0.94 [0.85-1.05],0.277000103748576
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCN5,CCN family member 5,Inverse variance weighted,12,1.05 [0.92-1.19],0.479823333751689
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,0.94 [0.74-1.20],0.636707736669771
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,1.06 [1.00-1.12],0.0425312562870067
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,15,1.03 [0.93-1.15],0.547838295359561
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LGALS1,Galectin-1,Inverse variance weighted,7,0.97 [0.86-1.08],0.566761464777743
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,1.04 [0.93-1.15],0.493684676817026
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,0.91 [0.84-0.98],0.0110053107908031
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,34,0.94 [0.86-1.01],0.0978034720360922
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PLA2G1B,Phospholipase A2,Inverse variance weighted,21,1.02 [0.86-1.21],0.853145841720715
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CA14,Carbonic anhydrase 14,Inverse variance weighted,21,1.08 [0.91-1.28],0.388996254044475
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,17,1.08 [0.99-1.19],0.0833875667071054
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,AGRN,Agrin,Inverse variance weighted,31,0.88 [0.79-0.98],0.0232787631615974
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EFNA4,Ephrin-A4,Inverse variance weighted,5,1.10 [0.83-1.47],0.496729807768967
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,38,1.06 [0.99-1.14],0.11884284289272
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,27,0.98 [0.88-1.08],0.646392446379507
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,OGN,Mimecan,Inverse variance weighted,37,0.96 [0.88-1.05],0.382157678526854
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.02 [0.94-1.11],0.578642274100351
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,0.95 [0.70-1.30],0.766876434554012
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.12 [0.92-1.37],0.240875250387695
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD46,Membrane cofactor protein,Inverse variance weighted,3,0.71 [0.52-0.97],0.0339580546498871
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.93 [0.87-1.00],0.0395216181700748
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CDH6,Cadherin-6,Inverse variance weighted,34,1.05 [0.98-1.12],0.144006189847211
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,1.00 [0.95-1.05],0.971441600311835
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPON2,Spondin-2,Inverse variance weighted,8,1.03 [0.89-1.19],0.677046616930123
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,BSG,Basigin,Inverse variance weighted,8,0.92 [0.75-1.13],0.429596502802971
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,0.97 [0.87-1.08],0.539083296490196
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,22,0.99 [0.90-1.09],0.836564840465264
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.99 [0.94-1.04],0.655379313867185
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD160,CD160 antigen,Inverse variance weighted,36,0.94 [0.85-1.03],0.152712390114284
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CYTL1,Cytokine-like protein 1,Inverse variance weighted,10,0.98 [0.93-1.03],0.426338712658991
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.92 [0.78-1.09],0.331719249404166
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,0.93 [0.83-1.04],0.216479038397881
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,9,1.04 [0.82-1.31],0.749905699432194
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VASN,Vasorin,Inverse variance weighted,19,1.03 [0.96-1.11],0.34649445533824
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.93 [0.79-1.11],0.428566518956076
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,0.99 [0.91-1.07],0.724238076469045
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EDN1,Endothelin-1,Inverse variance weighted,3,1.06 [0.81-1.37],0.686627351729639
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PRELP,Prolargin,Inverse variance weighted,14,1.02 [0.91-1.14],0.772665434590825
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,0.97 [0.88-1.07],0.555386908615317
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,1.02 [0.92-1.13],0.771522003510874
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,OMD,Osteomodulin,Inverse variance weighted,15,1.09 [0.92-1.29],0.296533701130966
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.99 [0.94-1.05],0.822634105314039
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.87 [0.68-1.10],0.241882178385396
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,0.98 [0.92-1.05],0.541650243881951
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.03 [0.83-1.28],0.777498785448798
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.02 [0.87-1.19],0.811929494249309
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,1.07 [0.91-1.26],0.441379539473155
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPP1,Osteopontin,Inverse variance weighted,19,1.00 [0.81-1.23],0.97650126429633
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,69,1.05 [0.99-1.10],0.0883109597534745
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.84 [0.60-1.17],0.302440285918005
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.84 [0.50-1.39],0.490430980003041
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,29,0.96 [0.89-1.04],0.330246159281691
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.07 [0.98-1.17],0.151274157785867
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,5,1.02 [0.74-1.42],0.89680860436903
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.04 [0.97-1.12],0.284394022546068
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.92 [0.78-1.09],0.334113639255885
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,XCL1,Lymphotactin,Inverse variance weighted,47,0.95 [0.89-1.00],0.0483549024683532
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.93 [0.70-1.23],0.620241675168531
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.07 [0.92-1.24],0.365865352097792
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,1.05 [0.92-1.20],0.468690186384652
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPRR3,Small proline-rich protein 3,Inverse variance weighted,17,1.05 [0.93-1.18],0.444672342540259
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LGALS4,Galectin-4,Inverse variance weighted,19,1.05 [0.94-1.17],0.413842214892031
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LAYN,Layilin,Inverse variance weighted,23,1.05 [0.94-1.16],0.392836417779357
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GPC1,Glypican-1,Inverse variance weighted,43,0.98 [0.92-1.05],0.595688339773371
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,20,0.94 [0.82-1.09],0.430879761631589
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,28,0.98 [0.92-1.04],0.54716812359676
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,28,0.93 [0.86-1.01],0.0710100983008397
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,1.06 [0.99-1.13],0.0952829349529079
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.03 [0.86-1.22],0.763262990952618
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.82 [0.41-1.65],0.574408447269997
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,0.98 [0.91-1.06],0.660639698749119
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.70 [0.84-3.45],0.140785763744212
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.22 [0.77-1.93],0.389371160359908
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.06 [0.92-1.21],0.432836337098141
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,0.82 [0.66-1.02],0.0755130570369899
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,1.17 [1.02-1.35],0.0243807760325737
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,0.96 [0.86-1.07],0.441137561403063
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.96-1.06],0.672562137185247
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.12 [0.84-1.50],0.422558765374521
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.87 [0.71-1.07],0.202075854586537
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SBSN,Suprabasin,Inverse variance weighted,28,0.95 [0.89-1.02],0.190329574697186
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PCDHB15,Protocadherin beta-15,Inverse variance weighted,43,0.98 [0.93-1.03],0.476674584492152
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,1.02 [0.98-1.05],0.334162964315385
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,14,0.98 [0.85-1.13],0.78899684077084
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,0.94 [0.86-1.03],0.209823700609328
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,14,1.06 [0.93-1.21],0.351259851571912
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,0.91 [0.74-1.11],0.347951919940741
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,35,0.99 [0.92-1.06],0.762893853936095
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DSG3,Desmoglein-3,Inverse variance weighted,27,1.05 [0.95-1.16],0.307465602321399
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,0.94 [0.89-0.99],0.0210232822488057
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,59,0.97 [0.92-1.04],0.413110064973224
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,22,0.97 [0.84-1.13],0.698413672298216
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NECTIN4,Nectin-4,Inverse variance weighted,12,1.04 [0.93-1.16],0.529506092034065
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.13 [0.62-2.06],0.693126353452118
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,1.06 [0.99-1.14],0.116460782876626
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCN3,CCN family member 3,Inverse variance weighted,20,1.02 [0.90-1.15],0.737169967984768
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,0.96 [0.83-1.10],0.563583101533363
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.87 [0.65-1.17],0.350476576085144
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,1.04 [0.94-1.15],0.473071631399491
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,0.97 [0.92-1.02],0.275678686932347
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RGMB,RGM domain family member B,Inverse variance weighted,10,0.90 [0.76-1.06],0.218046361983648
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CDH1,Cadherin-1,Inverse variance weighted,17,0.99 [0.87-1.11],0.831449286534067
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.29 [0.80-2.07],0.300543697655826
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CX3CL1,Fractalkine,Inverse variance weighted,23,1.04 [0.92-1.18],0.510067161736217
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.03 [0.88-1.22],0.693376230773702
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,JAM3,Junctional adhesion molecule C,Inverse variance weighted,8,1.23 [0.98-1.55],0.0711191657197376
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,0.95 [0.80-1.13],0.568085565970087
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LGALS9,Galectin-9,Inverse variance weighted,39,1.10 [1.02-1.19],0.0112050875241761
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SNCG,Gamma-synuclein,Inverse variance weighted,49,0.97 [0.92-1.03],0.333457146692449
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,27,1.02 [0.93-1.11],0.73955109081638
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,0.98 [0.90-1.05],0.535783329955775
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.15 [0.95-1.40],0.150940449776284
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.01 [0.65-1.57],0.974503962183312
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SERPINB8,Serpin B8,Inverse variance weighted,29,1.00 [0.96-1.05],0.889707872649542
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.31 [0.73-2.36],0.359710227743664
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.04 [0.93-1.16],0.479818249071075
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,22,1.01 [0.92-1.10],0.854803368184338
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.03 [0.84-1.26],0.77662707122685
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD99,CD99 antigen,Inverse variance weighted,4,0.83 [0.60-1.13],0.232053261958606
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SEPTIN8,Septin-8,Inverse variance weighted,6,0.77 [0.59-1.01],0.0544113280928225
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,0.83 [0.71-0.98],0.0243737781522319
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FOLR1,Folate receptor alpha,Inverse variance weighted,10,1.02 [0.80-1.29],0.875200271682717
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RSPO3,R-spondin-3,Inverse variance weighted,11,0.96 [0.80-1.15],0.633118937860482
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.03 [0.91-1.17],0.664616609866301
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.89-1.11],0.908746467708944
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.90-1.16],0.698333306532331
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DSG2,Desmoglein-2,Inverse variance weighted,22,0.98 [0.87-1.11],0.78310525103226
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,11,1.08 [0.86-1.36],0.495780002170617
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,AMBP,Protein AMBP,Inverse variance weighted,5,1.16 [0.92-1.46],0.205961550256452
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,31,1.01 [0.96-1.05],0.771063596396525
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.98 [0.64-1.51],0.937828485637008
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [0.86-1.26],0.662254269388475
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.92 [0.70-1.20],0.531253486931608
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,0.90 [0.81-1.00],0.0457856773749663
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.94 [0.63-1.39],0.755909639503314
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.83 [0.66-1.04],0.10821297889808
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PGA4,Pepsin A-4,Inverse variance weighted,9,1.03 [0.76-1.40],0.850493388510348
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.99 [0.62-1.58],0.962884557530741
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SCGB1A1,Uteroglobin,Inverse variance weighted,49,1.03 [0.94-1.13],0.532417614462494
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,36,0.98 [0.92-1.05],0.569671872253377
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DKK3,Dickkopf-related protein 3,Inverse variance weighted,28,0.95 [0.87-1.03],0.206753957558111
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.02 [0.89-1.16],0.801669071329491
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DLL1,Delta-like protein 1,Inverse variance weighted,13,0.95 [0.77-1.17],0.623602867742335
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,15,0.85 [0.75-0.97],0.0168904750808282
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.05 [0.96-1.16],0.282356098339953
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,0.98 [0.92-1.05],0.603126696886906
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,1.49 [0.95-2.32],0.0798697586611229
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD302,CD302 antigen,Inverse variance weighted,17,1.02 [0.90-1.15],0.784012897272439
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DSC2,Desmocollin-2,Inverse variance weighted,16,1.01 [0.90-1.13],0.829080463788128
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,0.97 [0.91-1.04],0.409550069259552
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,0.95 [0.89-1.01],0.119423313403196
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,0.96 [0.91-1.02],0.212278919478952
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DRAXIN,Draxin,Inverse variance weighted,38,1.09 [1.01-1.19],0.0270089117681608
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,1.42 [0.99-2.04],0.0569193744242283
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,16,0.82 [0.69-0.98],0.0326832156367024
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.94 [0.78-1.12],0.466459383069274
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CSTB,Cystatin-B,Inverse variance weighted,25,1.00 [0.93-1.09],0.903455228302137
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,41,0.98 [0.93-1.04],0.574531929060452
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ADM,Pro-adrenomedullin,Inverse variance weighted,4,1.01 [0.84-1.21],0.925655940394065
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ANG,Angiogenin,Inverse variance weighted,25,1.07 [0.99-1.16],0.070275624017994
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LMNB2,Lamin-B2,Inverse variance weighted,9,1.21 [0.92-1.59],0.168768625263018
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL19,Interleukin-19,Inverse variance weighted,21,1.01 [0.93-1.10],0.804346240715959
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,1.14 [1.03-1.27],0.0099770255941716
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,0.99 [0.87-1.11],0.81345692661983
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.03 [0.88-1.21],0.705942462430577
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.04 [0.80-1.35],0.79710718018827
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.08 [0.56-2.09],0.822016596876433
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.11 [1.01-1.22],0.0258969782641279
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.03 [0.99-1.07],0.208433411905649
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,S100G,Protein S100-G,Inverse variance weighted,4,0.89 [0.61-1.30],0.55794054743599
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CTSV,Cathepsin L2,Inverse variance weighted,34,1.03 [0.94-1.14],0.514633165115719
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DLK1,Protein delta homolog 1,Inverse variance weighted,33,1.02 [0.94-1.10],0.651741958555951
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,0.95 [0.85-1.07],0.387480740885501
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,0.98 [0.87-1.10],0.686114843117704
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.90 [0.69-1.16],0.402934876288413
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,1.01 [0.96-1.07],0.629589083887626
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.80 [0.68-0.95],0.0089813042807987
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CHAD,Chondroadherin,Inverse variance weighted,15,0.96 [0.87-1.06],0.428824069186014
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,1.00 [0.95-1.06],0.929049144539564
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.28 [1.08-1.53],0.00558358417015
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.72 [0.50-1.03],0.0723752609347048
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,37,1.08 [0.99-1.18],0.0826578051061248
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,0.74 [0.43-1.29],0.290068593378167
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RGMA,Repulsive guidance molecule A,Inverse variance weighted,47,0.96 [0.89-1.03],0.20859814620992
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.10 [0.98-1.23],0.109901947750381
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.98 [0.79-1.21],0.820138884563506
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,75,0.99 [0.95-1.02],0.478956008315062
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CTSL,Cathepsin L1,Inverse variance weighted,29,0.99 [0.85-1.14],0.844281499560416
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.01 [0.88-1.15],0.895697077684832
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,0.72 [0.57-0.92],0.007765621005511
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.92 [0.86-1.00],0.0404955907389203
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ANXA5,Annexin A5,Inverse variance weighted,2,1.29 [0.83-2.01],0.249225688165063
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,COLEC12,Collectin-12,Inverse variance weighted,13,0.96 [0.83-1.12],0.623107030825798
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,11,1.02 [0.82-1.26],0.881465896938212
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,15,0.93 [0.78-1.12],0.458621858031592
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.02 [0.72-1.46],0.907077106996681
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.13 [0.84-1.53],0.430304037432681
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MSMB,Beta-microseminoprotein,Inverse variance weighted,92,1.05 [1.01-1.09],0.010701245141847
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCL27,C-C motif chemokine 27,Inverse variance weighted,12,0.97 [0.83-1.14],0.72057886750582
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CALB1,Calbindin,Inverse variance weighted,11,1.09 [0.88-1.35],0.44079419224322
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.89 [0.63-1.26],0.51994556259973
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.99 [0.85-1.17],0.942182779576965
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.09 [0.81-1.46],0.581702594261504
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SEZ6L,Seizure 6-like protein,Inverse variance weighted,18,0.88 [0.78-1.00],0.0485601475133113
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.15 [0.95-1.40],0.161260737759572
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,0.94 [0.88-1.00],0.0561821316749342
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GUCA2A,Guanylin,Inverse variance weighted,16,1.00 [0.87-1.15],0.981042992600755
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.97 [0.88-1.07],0.565142242449269
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.87 [0.69-1.10],0.239949222302047
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CDHR1,Cadherin-related family member 1,Inverse variance weighted,19,1.10 [0.96-1.27],0.155352955404385
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,8,1.05 [0.87-1.27],0.597275775088162
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,27,1.01 [0.95-1.07],0.713113218628283
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,24,1.07 [0.95-1.20],0.249011450638619
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPARCL1,SPARC-like protein 1,Inverse variance weighted,62,0.99 [0.94-1.05],0.791732959518848
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SPON1,Spondin-1,Inverse variance weighted,25,1.09 [0.98-1.21],0.0983939187287358
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LGALS3,Galectin-3,Inverse variance weighted,42,0.99 [0.92-1.06],0.785092676134483
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EFNA1,Ephrin-A1,Inverse variance weighted,15,1.10 [0.99-1.22],0.0780841833293861
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD27,CD27 antigen,Inverse variance weighted,18,0.96 [0.85-1.08],0.505602447057372
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.06 [0.76-1.46],0.741771527298031
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.02 [0.93-1.11],0.705395136864854
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,1.05 [0.43-2.54],0.912826338784564
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,0.96 [0.87-1.05],0.372756029265921
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.94-1.04],0.677228015386937
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,8,1.13 [0.86-1.49],0.388896081348084
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.06 [0.95-1.19],0.280258805672564
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PCDH17,Protocadherin-17,Inverse variance weighted,47,0.97 [0.91-1.04],0.375901971054661
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,1.02 [0.86-1.21],0.807012849621523
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,16,0.95 [0.82-1.10],0.509859250426334
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,XG,Glycoprotein Xg,Inverse variance weighted,2,0.65 [0.20-2.11],0.472165617823329
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,6,0.93 [0.77-1.13],0.468945206727411
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.20 [1.02-1.41],0.0277529345248341
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,24,0.96 [0.87-1.07],0.495720961320593
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,8,1.08 [0.93-1.26],0.325355289279639
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,15,1.03 [0.91-1.15],0.657943890455787
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,F3,Tissue factor,Inverse variance weighted,26,1.01 [0.90-1.14],0.855184220433699
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,1.01 [0.93-1.10],0.782574195030324
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CALCA,Calcitonin,Inverse variance weighted,17,1.00 [0.78-1.29],0.978366117063424
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.11 [0.82-1.50],0.493359809086754
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,15,1.01 [0.95-1.07],0.718478537236027
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VGF,Neurosecretory protein VGF,Inverse variance weighted,2,0.83 [0.51-1.34],0.441365404736782
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,OCLN,Occludin,Inverse variance weighted,3,0.99 [0.75-1.30],0.929562392008612
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,39,1.02 [0.94-1.11],0.662740238757547
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,10,0.80 [0.68-0.94],0.0065304926759054
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CDH15,Cadherin-15,Inverse variance weighted,22,0.91 [0.83-0.99],0.0344092305436976
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,49,1.07 [1.01-1.12],0.0167305432020587
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,AREG,Amphiregulin,Inverse variance weighted,7,0.91 [0.74-1.12],0.369444234902627
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.98 [0.61-1.58],0.933456216347753
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,23,0.94 [0.82-1.07],0.336234072165403
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.98 [0.72-1.32],0.872377004028507
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RSPO1,R-spondin-1,Inverse variance weighted,14,0.96 [0.83-1.12],0.613432215941322
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FBLN2,Fibulin-2,Inverse variance weighted,17,1.00 [0.91-1.10],0.951784764970703
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,1.01 [0.91-1.12],0.850402404654003
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.93 [0.84-1.03],0.163840873772741
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,INHBB,Inhibin beta B chain,Inverse variance weighted,16,0.88 [0.73-1.05],0.155394405111054
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,2.06 [0.81-5.20],0.127380589205543
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCL11,Eotaxin,Inverse variance weighted,11,0.90 [0.78-1.04],0.160129414813731
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.02 [0.84-1.24],0.858035999962508
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,1.02 [0.96-1.08],0.629988370977109
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,0.94 [0.84-1.05],0.277713470877414
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,1.06 [0.96-1.16],0.24604776312607
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.85 [0.45-1.60],0.618899414403064
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.95 [0.87-1.03],0.229961512783865
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VIT,Vitrin,Inverse variance weighted,38,0.96 [0.91-1.01],0.132058609064428
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,27,0.82 [0.71-0.94],0.0053938109439182
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.11 [0.98-1.26],0.110511225369569
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.72 [0.11-4.80],0.733175368958621
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.00 [0.90-1.11],0.953596004485098
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.98 [0.88-1.09],0.707168145515071
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,1.03 [0.92-1.16],0.634267312488619
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KLK6,Kallikrein-6,Inverse variance weighted,6,1.15 [0.97-1.38],0.113174917902128
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.06 [0.98-1.14],0.130422991718174
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.91 [0.81-1.03],0.12318018485786
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RBP2,Retinol-binding protein 2,Inverse variance weighted,6,0.73 [0.48-1.12],0.146058174345607
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,0.99 [0.93-1.05],0.708964077008111
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,23,1.00 [0.94-1.07],0.880033150259789
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,0.97 [0.83-1.12],0.659900700910975
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.11 [0.97-1.27],0.117089174029057
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.17 [0.97-1.42],0.0937652529213701
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,26,1.00 [0.85-1.17],0.987063270600801
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,26,0.92 [0.84-1.01],0.0890176946175995
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,POF1B,Protein POF1B,Inverse variance weighted,4,0.83 [0.59-1.16],0.26720405553042
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.89 [0.70-1.13],0.334866138319557
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.93 [0.67-1.29],0.671183275499889
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.01 [0.95-1.07],0.818413801673561
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MB,Myoglobin,Inverse variance weighted,10,0.93 [0.73-1.18],0.54083193490399
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VCAN,Versican core protein,Inverse variance weighted,58,0.93 [0.88-1.00],0.0376840709231351
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,40,1.03 [0.94-1.13],0.576415963349787
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.89 [0.80-1.00],0.0544398108552694
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PI3,Elafin,Inverse variance weighted,20,1.05 [0.95-1.16],0.362183632104508
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.03 [0.88-1.21],0.710077376713306
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,1.07 [0.86-1.35],0.542566345060269
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.60 [0.37-0.98],0.0398784910459269
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Inverse variance weighted,3,1.19 [0.77-1.85],0.423722256708154
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NUCB2,Nucleobindin-2,Inverse variance weighted,28,0.92 [0.83-1.02],0.109538015056513
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DCN,Decorin,Inverse variance weighted,3,1.28 [0.74-2.20],0.37990709507836
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,0.92 [0.78-1.10],0.357041269974315
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PCDH12,Protocadherin-12,Inverse variance weighted,17,1.08 [0.93-1.25],0.30365579210251
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.03 [0.96-1.10],0.425100083806868
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,1.21 [1.02-1.44],0.0265656177690803
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,0.97 [0.90-1.05],0.461253319217537
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.98 [0.87-1.09],0.700585757624358
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,0.91 [0.84-0.99],0.0209862388154437
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCN4,CCN family member 4,Inverse variance weighted,40,1.04 [0.97-1.11],0.286280431392414
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,0.97 [0.79-1.18],0.766175859052016
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KLK11,Kallikrein-11,Inverse variance weighted,19,0.96 [0.89-1.04],0.308214709887244
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MMP7,Matrilysin,Inverse variance weighted,15,1.01 [0.91-1.11],0.869999879766838
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CALB2,Calretinin,Wald ratio,1,1.50 [0.80-2.78],0.20406242781088
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,MMP10,Stromelysin-2,Inverse variance weighted,30,1.05 [0.96-1.14],0.270015070546119
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,1.01 [0.94-1.08],0.829745664904152
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.15 [0.95-1.40],0.156236162006817
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VWC2,Brorin,Inverse variance weighted,35,1.06 [0.95-1.17],0.28153377482905
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,0.98 [0.87-1.10],0.69186045758061
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PENK,Proenkephalin-A,Inverse variance weighted,21,1.01 [0.90-1.13],0.858474140852557
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FABP6,Gastrotropin,Inverse variance weighted,5,1.06 [0.82-1.37],0.648653995832653
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,29,0.99 [0.92-1.06],0.744495311360351
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FAM3D,Protein FAM3D,Inverse variance weighted,56,1.01 [0.95-1.08],0.688538350864705
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,1.11 [0.99-1.25],0.0635847171668188
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.23 [1.04-1.44],0.013725261886642
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,1.14 [1.05-1.24],0.0018499406071005
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,DPT,Dermatopontin,Inverse variance weighted,26,1.02 [0.91-1.15],0.697957219096964
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NECTIN2,Nectin-2,Inverse variance weighted,8,0.97 [0.87-1.08],0.525138590019255
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.08 [0.90-1.30],0.427098671064529
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.95-1.09],0.558366072391892
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.00 [0.94-1.07],0.909494829237362
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PALM2,Paralemmin-2,Inverse variance weighted,9,1.11 [0.95-1.29],0.183026403639219
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,1.09 [0.86-1.38],0.491350690789438
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.86 [0.55-1.35],0.517029671583718
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.30 [0.77-2.20],0.32047614993771
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.10 [0.89-1.37],0.366366836184756
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.33 [0.15-0.71],0.0049013505423379
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.88 [0.64-1.19],0.394328387947519
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,1.09 [0.96-1.23],0.192998647746236
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,3,1.15 [0.69-1.92],0.594071087351411
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,24,1.05 [0.94-1.18],0.358393641929558
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,19,0.93 [0.84-1.03],0.155640218672623
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,PPL,Periplakin,Inverse variance weighted,2,0.93 [0.56-1.53],0.773326553380641
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,APOA2,Apolipoprotein A-II,Inverse variance weighted,16,1.02 [0.85-1.21],0.85042762337464
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.83 [0.67-1.02],0.075893727531109
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,SHISA5,Protein shisa-5,Inverse variance weighted,16,0.73 [0.56-0.95],0.0176466885311669
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,4,1.06 [0.73-1.54],0.754873961276074
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,12,0.79 [0.67-0.95],0.0109979685288774
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.21 [0.76-1.93],0.416727786561114
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CDH3,Cadherin-3,Inverse variance weighted,12,1.04 [0.79-1.35],0.801890761749189
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RBP7,Retinoid-binding protein 7,Inverse variance weighted,15,0.98 [0.84-1.14],0.755029382626829
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.04 [0.67-1.61],0.867274197589706
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,0.86 [0.67-1.11],0.257956390292739
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,9,0.91 [0.70-1.17],0.453219861490261
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,1.01 [0.92-1.12],0.829351967596011
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,0.95 [0.80-1.13],0.546939609236317
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,1.03 [0.88-1.21],0.701340105822038
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,34,0.97 [0.91-1.03],0.371928413751714
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,44,0.98 [0.95-1.01],0.192643869368168
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,0.96 [0.87-1.06],0.416001804195951
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,STC1,Stanniocalcin-1,Inverse variance weighted,11,1.12 [0.95-1.33],0.176514578725899
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,0.93 [0.83-1.04],0.220842916074204
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.99 [0.91-1.07],0.777100359805832
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,NXPH3,Neurexophilin-3,Inverse variance weighted,19,1.02 [0.94-1.11],0.624669552479494
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.02 [0.94-1.11],0.68627401203618
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL17C,Interleukin-17C,Inverse variance weighted,8,0.94 [0.73-1.20],0.607907285317388
"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,0.97 [0.87-1.09],0.613321375582529
